Abstract

Mycoplasma Pneumoniae (M.pneumoniae) is a well-known cause of atypical pneumonia, however it is also associated with many extra pulmonary manifestations. This report highlights a patient with gastroenterological, haematological and neurological complications, including a third cranial nerve palsy which developed after her initial treatment and discharge from hospital.

[download-attachments container="div" style="list" display_icon="1" display_count="1" display__size="0"]

References

1. Waites KB, Talkington DF. “Mycoplasma pneumoniae and its role as a human pathogen”, Clin Microbiol Rev. 2004; 17(4):697-728
2. Koskiniemi, M.”CNS manifestations associated with Mycoplasma pneumoniae infections: summary of cases at the University of Helsinki and review”, Clinical infectious diseases: an official publication of the Infectious Diseases Society of America, 1993;17(1):52-7.
3. Lee, S.Y., Lee, Y.H., Chun, B.Y., et al “An adult case of Fisher syndrome subsequent to Mycoplasma pneumoniae infection”, Journal of Korean medical science. 2013; 28(1): 152-155.
4. Salzman, M.B., Sood, S.K., Slavin, M.L. et al “Ocular manifestations of Mycoplasma pneumoniae infection”, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 1992; 14(5): 1137-1139.
5. Liu, E.M. & Janigian, R.H. “Mycoplasma pneumoniae: The Other Masquerader”, JAMA ophthalmology. 2013; 131(2): 251-253.
6. Wang, C., Chou, M. & Huang, C. “Benign Isolated Abducens Nerve Palsy in Mycoplasma pneumoniae Infection”, Pediatric neurology. 1998; 18(1): 71-72.
7. Yiş, U., Kurul, S.H., Çakmakçı, H. et al. “Mycoplasma pneumoniae: nervous system complications in childhood and review of the literature”, European journal of pediatrics. 2008; 169(9):973-978.
8. Fink, C. & Butler, L. “A cranial nerve palsy associated with Mycoplasma pneumoniae infection”, British journal of ophthalmology. 1993; 77: 750-750.
9. Yang, J., Hooper, W.C., Phillips, D.J. et al. Regulation of proinflammatory cytokines in human lung epithelial cells infected with Mycoplasma pneumoniae. Infection and immunity. 2002. 70(7):3649-3655.
10. Komatsu, H., Kuroki, S., Shimizu, Y., et al. “Mycoplasma pneumoniae meningoencephalitis and cerebellitis with antiganglioside antibodies”, Pediatric neurology. 1998; 18(2): 160-164.
11. Labro, M.T. “Anti-inflammatory activity of macrolides: a new therapeutic potential?”, The Journal of antimicrobial chemotherapy. 1998; 41(2): 37-46.
12. Cunha, B.A. “Cytomegalovirus pneumonia: community-acquired pneumonia in immunocompetent hosts”, Infectious disease clinics of North America, 2010; 24(1):147-158.
13. Jacobi, C.A., Riessen, R., Schumacher, U., et al. “Life-threatening pneumonia caused by human cytomegalovirus and Mycoplasma pneumoniae coinfection in a young, immunocompetent patient”, Journal of medical microbiology, 2010; 59(8):980-983.
14. Wang, X., Yang, K., Wei, C., et al. “Coinfection with EBV/CMV and other respiratory agents in children with suspected infectious mononucleosis”, Virology journal, 2010; 7: 247-422.